FOCL · Edap TMS
AI read · Neutral
The AI's read
The delay came from hospital approval steps during the summer, and management said it did not reflect weaker demand. The company expects the delayed sales to close in Q4. Still, compensation and marketing costs increased. Sales growth and more money left after product costs are encouraging, but the missed quarter keeps the report mixed.